Pay in 4 interest-free payments of $5.05 Learn more
Ships within 48 hours · Estimated delivery Aug 10 - Aug 15
[PMID: 26476010] PubMed record related to this compound for laboratory literature review
Drug Formulation Drug formulation phase- Picture Courtesy: IUVO Bioscience Now, specific amount of active ingredients including molecules for vitamin b1, b6, and b12, water and excipients such as solvents, stabilizers, and tonicity adjusters are combined
It was found that CB-839 could synergize with other anticancer drugs to exert beneficial therapeutic effects, and KRAS mutation led to enhanced glucose and glutamine metabolism in ovarian cancer cells, which was better inhibited by the combination of metformin and CB-839 [32]
10.1001/jama.2009.2008 43 FenechM
Clinical Context of the Protocol Each compound in the alleged stack carries a distinct pharmacological profile
